FDA

On Monday, Palantir Technologies Inc. (NASDAQ:PLTR) co-founder Joe Lonsdale urged a tech-driven transformation of the Food and Drug Administration, warning that bureaucratic inertia is putting the U.S. behind China in the biotech race. What Happened: In a blog post, Lonsdale said the FDA's current...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr., who is making strides in his war against synthetic food dyes, is now targeting colorful favorites such as Jell-O snacks, Kool-Aid and Lucky Charms cereals. By the end of 2027, many of these products are meant to be free of...

The U.S. Food and Drug Administration (FDA) on Wednesday initiated an immediate review of clinical trials that involved sending Americans’ living cells to China and other foreign adversaries for genetic engineering and subsequent infusion back into U.S. patients, sometimes without their...

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) for adult patients with bullous pemphigoid (BP), a rare, chronic autoimmune skin disorder. BP primarily affects elderly...

The U.S. Food and Drug Administration (FDA) announced its Commissioner's National Priority Voucher (CNPV) program. What Happened: The FDA aims to modernize its regulatory framework to meet emerging public health needs. Drug developers may redeem the new voucher to participate in the FDA’s...

The U.S. Food and Drug Administration (FDA) expanded approval of Moderna Inc.’s (NASDAQ:MRNA) respiratory syncytial virus vaccine to adults aged 18-59 at increased risk for disease. What Happened: The FDA on Thursday approved broader use of Moderna’s mRESVIA vaccine for younger at-risk...

The American Pharmacists Association announced Monday it will withhold endorsement of the Centers for Disease Control and Prevention’s updated immunization schedule that removed COVID-19 vaccine recommendations for pregnant women and healthy children. What Happened: The CDC modified its...

U.S. Health Secretary Robert F. Kennedy Jr. has championed “medical freedom” while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health experts call a dichotomy in his approach to healthcare policy. What Happened: Kennedy...

Over the past few weeks, a cascade of federal moves has reshaped the conversation around psychedelic-assisted therapy in the United States. What was once a fringe issue is now drawing bipartisan attention—and, increasingly, institutional support. The clearest signal came from FDA Commissioner Dr....

A new study has warned that declining childhood vaccination rates in the United States could trigger a dramatic resurgence of diseases that were eradicated years ago. What Happened: On Sunday, former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb shared a study on X...

The U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will no longer recommend COVID-19 vaccines for healthy children and pregnant women, sparking criticism from public health experts who cite ongoing risks. What Happened:...

The U.S. Food and Drug Administration (FDA) approved Eton Pharmaceuticals, Inc.’s (NASDAQ:ETON) new drug application (NDA) for Khindivi (hydrocortisone) oral solution as a replacement therapy for pediatric patients five years of age and older with adrenocortical insufficiency. Adrenocortical...

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults. What Happened: The FDA will now require new...

U.S. Health Secretary Robert Kennedy Jr. praised the Food and Drug Administration’s decision to begin removing fluoride supplements for children from the market, calling the move “long overdue.” What Happened: The FDA announced on Tuesday that it’s initiating a process to...

President Donald Trump signed an executive order Monday directing the Food and Drug Administration to accelerate approvals for domestic pharmaceutical manufacturing facilities as his administration prepares to announce new tariffs on imported medicines within two weeks. What Happened: The executive...